Customized Viral Immunotherapy for HPV-Associated Cancer

Atherton, MJ; Stephenson, KB; Pol, J; Wang, FA; Lefebvre, C; Stojdl, DF; Nikota, JK; Dvorkin-Gheva, A; Nguyen, A; Chen, L; Johnson-Obaseki, S; Villeneuve, PJ; Diallo, JS; Dimitroulakos, J; Wan, YH; Lichty, BD

Lichty, BD (reprint author), McMaster Univ, 1200 Main St West MDCL 5023, Hamilton, ON L8N 3Z5, Canada.

CANCER IMMUNOLOGY RESEARCH, 2017; 5 (10): 847

Abstract

The viral-transforming proteins E6 and E7 make human papillomavirus-positive (HPV+) malignancies an attractive target for cancer immunotherapy. Howeve......

Full Text Link